Protein Plus: Improving Infant Growth Through Diet and Enteric Health
Status:
Active, not recruiting
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
This cluster-randomized controlled trial is designed to address linear growth faltering in
6-12-mo-old Bangladesh infants through a proof-of-concept package of interventions to a)
increase intake of high quality protein and b) control enteric pathogens.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborators:
Bill and Melinda Gates Foundation International Centre for Diarrhoeal Disease Research, Bangladesh